Goldman Sachs Downgrades Laboratory Corporation of America (LH) to Buy

Goldman Sachs analyst Patrick Donnelly downgraded Laboratory Corporation of America (NYSE: LH) from Conviction Buy to Buy with a price target of $180.00 (from $190.00).

The analyst views the company as a Top Pick in the Lab industry but removes from the Conviction Buy List as it has underperformed the broad index since being added back in January 2018.

For an analyst ratings summary and ratings history on Laboratory Corporation of America click here. For more ratings news on Laboratory Corporation of America click here.

Shares of Laboratory Corporation of America closed at $161.81 yesterday.

You May Also Be Interested In

• Morgan Stanley Upgrades Telecom Argentina (TEO) to Overweight
• Bank of Queensland Ltd. (BOQ:AU) (BKQNY) PT Lowered to AUD6.80 at UBS
• Bendigo & Adelaide Bank Ltd (BEN:AU) (BXRBF) PT Lowered to AUD11.30 at UBS